Global Economic Intersection
Advertisement
  • Home
    • 카지노사이트
  • Economics
  • Finance
  • Politics
  • Investments
    • Invest in Amazon $250
  • Cryptocurrency
    • Best Bitcoin Accounts
    • Bitcoin Robot
      • Quantum AI
      • Bitcoin Era
      • Bitcoin Aussie System
      • Bitcoin Profit
      • Bitcoin Code
      • eKrona Cryptocurrency
      • Bitcoin Up
      • Bitcoin Prime
      • Yuan Pay Group
      • Immediate Profit
      • BitQH
      • Bitcoin Loophole
      • Crypto Boom
      • Bitcoin Treasure
      • Bitcoin Lucro
      • Bitcoin System
      • Oil Profit
      • The News Spy
      • Bitcoin Buyer
      • Bitcoin Inform
      • Immediate Edge
      • Bitcoin Evolution
      • Cryptohopper
      • Ethereum Trader
      • BitQL
      • Quantum Code
      • Bitcoin Revolution
      • British Trade Platform
      • British Bitcoin Profit
    • Bitcoin Reddit
    • Celebrities
      • Dr. Chris Brown Bitcoin
      • Teeka Tiwari Bitcoin
      • Russell Brand Bitcoin
      • Holly Willoughby Bitcoin
No Result
View All Result
  • Home
    • 카지노사이트
  • Economics
  • Finance
  • Politics
  • Investments
    • Invest in Amazon $250
  • Cryptocurrency
    • Best Bitcoin Accounts
    • Bitcoin Robot
      • Quantum AI
      • Bitcoin Era
      • Bitcoin Aussie System
      • Bitcoin Profit
      • Bitcoin Code
      • eKrona Cryptocurrency
      • Bitcoin Up
      • Bitcoin Prime
      • Yuan Pay Group
      • Immediate Profit
      • BitQH
      • Bitcoin Loophole
      • Crypto Boom
      • Bitcoin Treasure
      • Bitcoin Lucro
      • Bitcoin System
      • Oil Profit
      • The News Spy
      • Bitcoin Buyer
      • Bitcoin Inform
      • Immediate Edge
      • Bitcoin Evolution
      • Cryptohopper
      • Ethereum Trader
      • BitQL
      • Quantum Code
      • Bitcoin Revolution
      • British Trade Platform
      • British Bitcoin Profit
    • Bitcoin Reddit
    • Celebrities
      • Dr. Chris Brown Bitcoin
      • Teeka Tiwari Bitcoin
      • Russell Brand Bitcoin
      • Holly Willoughby Bitcoin
No Result
View All Result
Global Economic Intersection
No Result
View All Result

3 Companies Working to Prevent an Ebola Outbreak

admin by admin
October 9, 2014
in Uncategorized
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

by Josh Grasmick, Daily Reckoning

After years of fighting on the market and searching in labs for answers to the human body… Medical innovators are now in the spotlight.

Their share prices are often jumping up double digits in days, or even hours.

You know why it’s happening, right?

They’re trading on news of the deadliest and most complex Ebola virus in living memory (out of 20 in the past four decades).

“It’s the single greatest concern I’ve ever had in my 40-year public health career…”

Today, I want to show you how to profit from vaccines and treatments for an Ebola epidemic. But first, we have to answer a very important question: Is Ebola all hype?

You’ve heard stories like this before…

Five years ago, swine flu was supposed to put nearly 2 million people in the hospital.

And just last year, a strain of Asian bird flu threatened to be “one of the most lethal” ever, according to the World Health Organization.

Little to nothing came of either of them.

What about Ebola?

The truth is that nobody knows.

And what our government does know is trickling out little by little… maybe to prevent mass hysteria, maybe not.

It is curious, though, what our government has been releasing.

For example, President Obama’s executive order to amend a subsection of a “quarantine” protocol for respiratory viruses went virtually unnoticed… when Ebola first broke African borders.

They did this because, as of now, Ebola spreads through direct contact. That means if you are exposed to an Ebola patient’s blood or bodily fluids (urine, saliva, feces, vomit and semen).

But President Obama made his executive order in the event of the worst-case scenario: if Ebola goes airborne. If you can cough and infect someone, that would be the greatest trigger to an epidemic that expands anywhere and everywhere.

“It’s the single greatest concern I’ve ever had in my 40-year public health career,” said Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. “I can’t imagine anything in my career – and this includes HIV – that would be more devastating to the world than a respiratory transmissible Ebola virus.”

As the virus spreads and mutates, Osterhold and other experts warn, the likelihood increases.

Osterholm calls it “genetic roulette.”

One thing is for certain: We have to be prepared if the problem escalates. And if it does, there’s a very high chance U.S. technology will ultimately save the day.

How come? Consider the case of Thomas Eric Duncan, the now notorious Liberian citizen who fled his native homeland of overcrowded hospitals… went through Brussels Airport (in Belgium)… to Dulles Airport (near Washington, D.C.)… and then to Dallas/Fort Worth to get treatment here in the U.S.

He didn’t stay in the other developed countries along the way.

Why? Well…

The U.S. has both the best supporting care system in the world and the most active drug market.

As a result, the U.S. offers the greatest possible access to an experimental drug.

Here, Duncan and many others will at least have a fighting chance to live.

Although he might be charged with a crime in his home country, the guy was just trying to save his own life (he’s now in critical condition).


What is the Income Play Rich Investors Love? (Hint: It’s Tax-Free)


Is he going to be the last one to do so? Heh…

The more realistic question is how many others will follow suit? It’s only a matter of time…

Refugees will increase rapidly, especially if, as the CDC predicts, the number of Africans infected with Ebola goes from thousands… to 1.4 million by January 2015.

With that spike comes risk to populations… demand for therapies, vaccines and cures… and investments in innovations.

There are 13 companies working on Ebola at the moment: seven on vaccines, six on other treatments. But as of now, there are no FDA-approved drugs for Ebola.

The U.S. government is so motivated to prevent a widespread crisis that they’ve imposed what’s called the “Animal Rule.”

“The Animal Rule,” says Paul Mampilly, editor of FDA Trader, “allows the FDA to give conditional approval to drugs if they work in animal studies.”

Why, Paul explains to us, is “because we’re going to need more than one drug to make sure, because the virus is adapting to us as we’re adapting to it. It mutates into different forms.”

Besides, we all have different DNA, and therefore different ways of reacting to certain drugs. Some drugs that work on one person may not work on another, and vice versa.

“…we’re going to need every single Ebola drug that we have to try to help these patients.”

“That means we’re going to need every single Ebola drug that we have to try to help these patients,” Paul goes on. “And then pray that they work.”

It’s the golden rule of investing: Diversify; don’t put all your eggs in one basket.

Skipping private companies like Mapp Biopharmaceutical… Here are three companies that we feel are top candidates for giving hope to this nightmare scenario:

3 Companies Working on Experimental Drugs for Ebola Virus

  1. BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) has a drug, unromantically named BCX4430 that is likely to be a second-line treatment. Second-line treatment just means you get it if the first drug fails. But don’t let that fool you. BioCryst’s drug could end up playing a critical role in helping patients. It has already shown that it may work against Ebola. So there’s still upside for it.
  2. Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) has an Ebola drug that was used successfully on a patient already – one reason why it’s been rallying so much. That patient was Richard Sacra, who was given the drug and survived. If this drug gets conditional approval, it could go up twice as much as BioCryst.
  3. Sarepta Therapeutics (NASDAQ:SRPT) is working on the problem from a therapeutic angle with an RNA molecule blocker to stop the virus upon infection (Ebola is an RNA virus – that means each time it copies itself, it makes at least another mutation). Already, there was evidence that showed this drug working in a different virus just last week: the flu. As our genius and cancer survivor turned biotech editor Ray Blanco says, “We don’t realize how deadly the flu is, but it kills tens of thousands of people in the U.S. It’s a variable figure, some years being much worse than others.” The National Institutes of Health, Ray reports, conducted a Phase 1 trial of Sarepta’s flu drug, the deceptively boring name of AVI-7100, with very high standards (randomized, placebo-controlled and double-blinded). “Not surprisingly, these innovators are leveraging their breakthrough vaccine technology to counter the Ebola threat,” Ray informs us.

Previous Post

17 September 2014 FOMC Meeting Minutes: Discussion of Global Downside Risks to USA Economy

Next Post

China Is The World’s Top Source Of Internet Attack Traffic

Related Posts

Unlocking the Future: Google's Game-Changing Move to Advertise NFT Games Starting September 15th
Business

Unlocking the Future: Google’s Game-Changing Move to Advertise NFT Games Starting September 15th

by John Wanguba
September 8, 2023
Bitcoin Is Finally Trading Perfectly Like 'Digital Gold'
Economics

Bitcoin Is Finally Trading Perfectly Like ‘Digital Gold’

by John Wanguba
August 5, 2023
Can Worldcoin Overtake Bitcoin?
Economics

Can Worldcoin Overtake Bitcoin?

by John Wanguba
August 4, 2023
Bitcoin Is Steady Above $29,000 Awaiting US NFP Figures
Economics

Bitcoin Is Steady Above $29,000 Awaiting US NFP Figures

by John Wanguba
August 4, 2023
Namibia Will Regulate And Not Ban Crypto With New Law
Finance

Namibia Will Regulate And Not Ban Crypto With New Law

by John Wanguba
July 25, 2023
Next Post

China Is The World's Top Source Of Internet Attack Traffic

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Browse by Category

  • Business
  • Econ Intersect News
  • Economics
  • Finance
  • Politics
  • Uncategorized

Browse by Tags

adoption altcoins bank banking banks Binance Bitcoin Bitcoin market blockchain BTC BTC price business China crypto crypto adoption cryptocurrency crypto exchange crypto market crypto regulation decentralized finance DeFi Elon Musk ETH Ethereum Europe Federal Reserve finance FTX inflation investment market analysis Metaverse NFT nonfungible tokens oil market price analysis recession regulation Russia stock market technology Tesla the UK the US Twitter

Archives

  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • August 2010
  • August 2009

Categories

  • Business
  • Econ Intersect News
  • Economics
  • Finance
  • Politics
  • Uncategorized
Global Economic Intersection

After nearly 11 years of 24/7/365 operation, Global Economic Intersection co-founders Steven Hansen and John Lounsbury are retiring. The new owner, a global media company in London, is in the process of completing the set-up of Global Economic Intersection files in their system and publishing platform. The official website ownership transfer took place on 24 August.

Categories

  • Business
  • Econ Intersect News
  • Economics
  • Finance
  • Politics
  • Uncategorized

Recent Posts

  • Unlocking the Future: Google’s Game-Changing Move to Advertise NFT Games Starting September 15th
  • Bitcoin Is Finally Trading Perfectly Like ‘Digital Gold’
  • Can Worldcoin Overtake Bitcoin?

© Copyright 2021 EconIntersect - Economic news, analysis and opinion.

No Result
View All Result
  • Home
  • Contact Us
  • Bitcoin Robot
    • Bitcoin Profit
    • Bitcoin Code
    • Quantum AI
    • eKrona Cryptocurrency
    • Bitcoin Up
    • Bitcoin Prime
    • Yuan Pay Group
    • Immediate Profit
    • BitIQ
    • Bitcoin Loophole
    • Crypto Boom
    • Bitcoin Era
    • Bitcoin Treasure
    • Bitcoin Lucro
    • Bitcoin System
    • Oil Profit
    • The News Spy
    • British Bitcoin Profit
    • Bitcoin Trader
  • Bitcoin Reddit

© Copyright 2021 EconIntersect - Economic news, analysis and opinion.